MedPath

Lorazepam

LORAZEPAM INTENSOL™ Oral Concentrate USP2 mg per mL

Approved
Approval ID

ee9e95a6-a9d7-43c1-ac3c-c9dc4b390760

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 18, 2009

Manufacturers
FDA

Physicians Total Care, Inc.

DUNS: 194123980

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

lorazepam

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code54868-6010
Application NumberANDA073079
Product Classification
M
Marketing Category
C73584
G
Generic Name
lorazepam
Product Specifications
Route of AdministrationORAL
Effective DateJune 17, 2010
FDA Product Classification

INGREDIENTS (3)

LORAZEPAMActive
Quantity: 2 mg in 1 mL
Code: O26FZP769L
Classification: ACTIM
POLYETHYLENE GLYCOLInactive
Code: 3WJQ0SDW1A
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Lorazepam - FDA Drug Approval Details